Your institution may have access to this item. Find your institution then sign in to continue.
Title
Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study.
Authors
Byrne, M J; Davidson, J A; Musk, A W; Dewar, J; van Hazel, G; Buck, M; de Klerk, N H; Robinson, B W
Abstract
We performed a phase II study of combined cisplatin 100 mg/m2, given intravenously on day 1, and gemcitabine 1,000 mg/m2, given intravenously on days 1, 8, and 15 of a 28-day cycle for six cycles among patients with advanced measurable pleural mesothelioma.
Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Vol 17, Issue 1, p25